First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

526 Reviews

Credit Rating - CENTRAL PHARMA BIOTECHNICA LIMITED

ANALYSIS
Credit Risk Update: ACCOUNTS DUE FLAG: CENTRAL PHARMA BIOTECHNICA LIMITED, CENTRAL PHARMA CAXTON ROAD, ELM FARM IND ESTATE, BEDFORD, MK41 0HT. The legal status is a Private Limited Company and the current status at the registry of companies is Active. The last filed accounts are dated 31 December 2022. The company was incorporated on 5 February 2021.

The accounts next due date is 30 September 2024. There are no mortgages.

The above was based on public record information as at 27 September 2024 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: 13182798
Date Incorporated: 5 February 2021
Date Latest Accounts: 31 December 2022
BUSINESS INFORMATION
Legal Form: Private Limited Company
Previous Names: None
Registered Number: 13182798
Annual Return: Unknown
Registered Office: CENTRAL PHARMA CAXTON ROAD, ELM FARM IND ESTATE, BEDFORD, MK41 0HT
SIC Code and Operations: 96090
SECURED CREDITORS
Number of Mortgages 0
Satisfied Mortgages 0
Part Satisfied Mortgages 0
Unsatisfied Mortgages 0
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

CENTRAL PHARMA BIOTECHNICA LIMITED

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 7 October 2024 Copyright © 2024 First Report Ltd


Recent Searches

Reg No. Reg Name Status
12769240 CENTRAL PHARMA CELL AND GENE THERAPY LTD Active
08126719 CENTRAL PHARMA CONTRACT HOLDINGS LIMITED Active
05666241 CENTRAL PHARMA CONTRACT PACKING LIMITED Active
13043335 CENTRAL PHARMA MANUFACTURING LTD Active
04786240 CENTRAL PHARMACEUTICALS (UK) LIMITED Liquidation

In using this service you agree to the Terms and Conditions

© 2024 First Report Ltd